铁死亡在黑素瘤中的研究进展

doi:10.35541/cjd.20220135

Abstract

Abstract: 【Abstract】 Ferroptosis, a newly discovered form of iron-dependent regulation of cell death, has been found to be associated with the development of various cancers, including melanoma. This review summarizes recent progress in roles of ferroptosis in the pathogenesis, metastasis and treatment of melanoma, aiming to provide a theoretical basis for the development of new drugs and new treatment strategies for melanoma in clinical practice.

Key words: Nevi and melanoma, Cell death, Lipid peroxidation, Ferroptosis

CLC Number:

R751

Zhang Congcong, Chen Hao. Ferroptosis in melanoma[J]. Chinese Journal of Dermatology,2022,e20220135. doi:10.35541/cjd.20220135

References ［34］

［1］	Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron⁃dependent form of nonapoptotic cell death［J］. Cell, 2012,149（5）:1060⁃1072. doi: 10.1016/j.cell.2012.03.042.
［2］	Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron⁃dependent, nonapoptotic cell death in oncogenic⁃RAS⁃harboring cancer cells［J］. Chem Biol, 2008,15（3）:234⁃245. doi: 10.1016/j.chembiol.2008.02.010.
［3］	Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018［J］. Cell Death Differ, 2018,25（3）:486⁃541. doi: 10.1038/s41418⁃017⁃0012⁃4.
［4］	Liu M, Kong XY, Yao Y, et al. The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review［J］. Ann Transl Med, 2022,10（6）:368. doi: 10.21037/atm⁃21⁃6942.
［5］	Conrad M, Pratt DA. The chemical basis of ferroptosis［J］. Nat Chem Biol, 2019,15:1137⁃1147. doi:10.1038/s41589⁃019⁃0408⁃1.
［6］	Gao M, Fan K, Chen Y, et al. Understanding the mechanistic regulation of ferroptosis in cancer: gene matters［J］. J Genet Genomics, 2022:S1673⁃8527（22）00160⁃6. ［2022⁃02⁃20］. doi: 10.1016/j.jgg.2022.06.002.
［7］	Benboubker V, Boivin F, Dalle S, et al. Cancer cell phenotype plasticity as a driver of immune escape in melanoma［J］. Front Immunol, 2022,13:873116. doi: 10.3389/fimmu.2022.873116.
［8］	Thier B, Zhao F, Stupia S, et al. Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity［J］. J Immunother Cancer, 2022,10（6）. doi: 10.1136/jitc⁃2021⁃003863.
［9］	Riesenberg S, Groetchen A, Siddaway R, et al. MITF and c⁃Jun antagonism interconnects melanoma dedifferentiation with pro⁃inflammatory cytokine responsiveness and myeloid cell recruitment［J］. Nat Commun, 2015,6:8755. doi: 10.1038/ncomms9755.
［10］	Tsoi J, Robert L, Paraiso K, et al. Multi⁃stage differentiation defines melanoma subtypes with differential vulnerability to drug⁃induced iron⁃dependent oxidative stress［J］. Cancer Cell, 2018,33（5）:890⁃904.e5. doi: 10.1016/j.ccell.2018.03.017.
［11］	Hanniford D, Ulloa⁃Morales A, Karz A, et al. Epigenetic silencing of CDR1as drives IGF2BP3⁃mediated melanoma invasion and metastasis［J］. Cancer Cell, 2020,37（1）:55⁃70.e15. doi: 10.1016/j.ccell.2019.12.007.
［12］	Sato M, Onuma K, Domon M, et al. Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice［J］. Int J Cancer, 2020,147（11）:3224⁃3235. doi: 10.1002/ijc.33262.
［13］	Leary N, Walser S, He Y, et al. Melanoma⁃derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes［J］. J Extracell Vesicles, 2022,11（2）:e12197. doi: 10.1002/jev2.12197.
［14］	Ubellacker JM, Tasdogan A, Ramesh V, et al. Lymph protects metastasizing melanoma cells from ferroptosis［J］. Nature, 2020,585（7823）:113⁃118. doi: 10.1038/s41586⁃020⁃2623⁃z.
［15］	de Groot E, Varghese S, Tan L, et al. Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor⁃resistant melanomas［J］. Cancer Metab, 2022,10（1）:6. doi: 10.1186/s40170⁃022⁃00281⁃0.
［16］	Gentric G, Kieffer Y, Mieulet V, et al. PML⁃regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers［J］. Cell Metab, 2019,29（1）:156⁃173.e10. doi: 10.1016/j.cmet.2018.09.002.
［17］	Gagliardi M, Cotella D, Santoro C, et al. Aldo⁃keto reductases protect metastatic melanoma from ER stress⁃independent ferroptosis［J］. Cell Death Dis, 2019,10（12）:902. doi: 10.1038/s41419⁃019⁃2143⁃7.
［18］	Osrodek M, Hartman ML, Czyz M. Physiologically relevant oxygen concentration （6% O（2）） as an important component of the microenvironment impacting melanoma phenotype and melanoma response to targeted therapeutics in vitro［J］. Int J Mol Sci, 2019,20（17）:4203. doi: 10.3390/ijms20174203.
［19］	Talebi A, Dehairs J, Rambow F, et al. Sustained SREBP⁃1⁃dependent lipogenesis as a key mediator of resistance to BRAF⁃targeted therapy［J］. Nat Commun, 2018,9（1）:2500. doi: 10. 1038/s41467⁃018⁃04664⁃0.
［20］	Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy⁃resistant state of cancer cells on a lipid peroxidase pathway［J］. Nature, 2017,547（7664）:453⁃457. doi: 10.1038/nature23007.
［21］	You JH, Lee J, Roh JL. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug⁃tolerant persister head and neck cancer cells via epithelial⁃mesenchymal transition［J］. Cancer Lett, 2021,507:40⁃54. doi: 10.1016/j.canlet.2021.03.013.
［22］	Wang W, Green M, Choi JE, et al. CD8（+） T cells regulate tumour ferroptosis during cancer immunotherapy［J］. Nature, 2019,569（7755）:270⁃274. doi: 10.1038/s41586⁃019⁃1170⁃y.
［23］	Lang X, Green MD, Wang W, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11［J］. Cancer Discov, 2019,9（12）:1673⁃1685. doi: 10.1158/2159⁃8290.CD⁃19⁃0338.
［24］	Jiang Z, Lim SO, Yan M, et al. TYRO3 induces anti⁃PD⁃1/PD⁃L1 therapy resistance by limiting innate immunity and tumoral ferroptosis［J］. J Clin Invest, 2021,131（8）:e139439. doi: 10.1172/JCI139434.
［25］	Zhu B, Tang L, Chen S, et al. Targeting the upstream transcriptional activator of PD⁃L1 as an alternative strategy in melanoma therapy［J］. Oncogene, 2018,37（36）:4941⁃4954. doi: 10.1038/s41388⁃018⁃0314⁃0.
［26］	Song R, Li T, Ye J, et al. Acidity⁃activatable dynamic nanoparticles boosting ferroptotic cell death for immunotherapy of cancer［J］. Adv Mater, 2021,33（31）:e2101155. doi: 10.1002/adma.202101155.
［27］	Xu C, Chen H. A ferroptosis⁃related gene model predicts prognosis and immune microenvironment for cutaneous melanoma［J］. Front Genet, 2021,12:697043. doi: 10.3389/fgene.2021.697043.
［28］	Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis［J］. Mol Cell, 2015,59（2）:298⁃308. doi: 10.1016/j.molcel.2015.06.011.
［29］	Luo M, Wu L, Zhang K, et al. MiR⁃137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma［J］. Cell Death Differ, 2018,25（8）:1457⁃1472. doi: 10.1038/s41418⁃017⁃0053⁃8.
［30］	Zhang K, Wu L, Zhang P, et al. MiR⁃9 regulates ferroptosis by targeting glutamic⁃oxaloacetic transaminase GOT1 in melanoma［J］. Mol Carcinog, 2018,57（11）:1566⁃1576. doi: 10.1002/mc. 22878.
［31］	Liao Y, Jia X, Ren Y, et al. Suppressive role of microRNA⁃130b⁃3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2⁃HO⁃1 pathway activation［J］. Hum Cell, 2021,34（5）:1532⁃1544. doi: 10.1007/s13577⁃021⁃00557⁃5.
［32］	王潇玉, 田阳子, 吴振杰, 等. MiR⁃210在黑素瘤细胞铁死亡中的作用和机制研究［J］. 现代生物医学进展, 2021,21（10）:1818⁃1823. doi: 10.13241/j.cnki.pmb.2021.10.004.
［33］	Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS⁃RAF⁃MEK⁃dependent oxidative cell death involving voltage⁃dependent anion channels［J］. Nature, 2007,447（7146）:864⁃868. doi: 10. 1038/nature05859.
［34］	Yang Y, Luo M, Zhang K, et al. Nedd4 ubiquitylates VDAC2/3 to suppress erastin⁃induced ferroptosis in melanoma［J］. Nat Commun, 2020,11（1）:433. doi: 10.1038/s41467⁃020⁃14324⁃x.

[1]	Yao Manxue, Zhou Naihui. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with programmed death-1/programmed death-ligand 1 inhibitors [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220644-e20220644.
[2]	Dong Dong, Liu Tianyi. Cell metabolism and metastasis of cutaneous malignant melanoma [J]. Chinese Journal of Dermatology, 2023, 56(9): 878-881.
[3]	Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462.
[4]	Yang Yongting, Li Tingting, Kang Xiaojing. Biomarkers related to the treatment of melanoma with immune checkpoint inhibitors [J]. Chinese Journal of Dermatology, 2023, 56(3): 278-283.
[5]	Wang Yuanli, Liu Ling, Sun Zhongbin, Li Kai. Analysis of 141 cases clinically misdiagnosed as melanoma [J]. Chinese Journal of Dermatology, 2023, 56(3): 244-246.
[6]	Zheng Nana, Zeng Rong, Tao Yingkai, Li Min, . Relationship between circular RNAs and skin tumors [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210893-e20210893.
[7]	Li Fang, Wang Xiaoqing, Liu Mengxi, Jiang Jiayi, Huang Shudai, Wang Daguang. Research advances in recurrent melanocytic nevus [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220431-e20220431.
[8]	Li Tingting, Kang Xiaojing. Gut microbiota and immune checkpoint inhibitor treatment of melanoma [J]. Chinese Journal of Dermatology, 2023, 56(2): 177-180.
[9]	Cao Meng, Hong Anlan, Wang Yan, Fang Fang. Clinical progress in pediatric melanoma [J]. Chinese Journal of Dermatology, 2023, 56(11): 1074-1078.
[10]	Shih Yanting, Li Hao, Zheng Jie, Cao Hua. Programmed death-1/programmed death ligand-1 signaling pathway in idiopathic inflammatory myopathies [J]. Chinese Journal of Dermatology, 2022, 55(7): 633-636.
[11]	Gao Ni, Liu Yu, Wang Lei, Liu Ling, Gao Tianwen, Li Kai . Clinical and histopathological analysis of five cases of solitary dermal melanoma [J]. Chinese Journal of Dermatology, 2022, 55(5): 408-410.
[12]	Zou Meirong, Wang Sheng. Cutaneous immune-related adverse reactions induced by immune checkpoint inhibitors [J]. Chinese Journal of Dermatology, 2022, 55(11): 1026-1030.
[13]	Guo Wei, Zhao Tao, Guo Weinan, Ma Cuiling, Gao Tianwen, Zhao Jianhong, Li Bing. Surgical treatment strategies and outcomes of early-stage nail apparatus melanoma: a retrospective analysis of 115 cases [J]. Chinese Journal of Dermatology, 2021, 54(9): 777-784.
[14]	Wang Daguang, Jiang Jiayi. Considerations in the diagnosis and treatment of several nail diseases [J]. Chinese Journal of Dermatology, 2021, 54(8): 733-737.
[15]	Yu Yingyuan, Li Ying, Yu Zengyang, Zheng Jianfeng, Zhang Xilin, Ding Yangfeng, Shi Yuling, . Efficacy and safety of infliximab in the treatment of severe plaque psoriasis and its effect on the expression of programmed cell death-1 and programmed cell death ligand-1 [J]. Chinese Journal of Dermatology, 2021, 54(7): 590-596.

Ferroptosis in melanoma

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［34］

Related Articles 15

Metrics

Comments

Recommended 10